New Delhi, May 06, 2024 (GLOBE NEWSWIRE) -- Astute Analytica states that the global apheresis market was valued at US$ 3,248.3 million in 2023 and is estimated to surpass market valuation of US$ 6,882 ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD symptoms ...
Familial hypercholesterolemia is an autosomal dominant disorder resulting in severe elevation of total and LDL cholesterol due to defective hepatic LDL receptor. Heterozygotes occur in about 1 of 500 ...
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial The study included CAR T-cell ...
The fifth annual Apheresis Awareness Day is recognized on Tuesday, September 17, 2024, as designated by the American Society for Apheresis (ASFA). The purpose is to raise awareness of apheresis ...
span class="inline inline-left">PHOTO: COURTESY OF SILOAM HOSPITALS LIPPO VILLAGE“Patients suffering from autoimmune diseases no longer need weeks or months of ...
“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...
During the projection period, it is predicted that demand for therapeutic apheresis would increase at a CAGR of 6.8%. The Therapeutic Apheresis Market share is anticipated to be worth US$ 2577.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results